Resultados: 6

Safety of incidental exposure to the novel oral poliovirus vaccine type 2 in pregnancy: A longitudinal observational study in Mozambique, 2022-2023

Vaccine; 15 (), 2024
To minimize the risk of vaccine-derived poliovirus emergences, the novel oral poliovirus vaccine type 2 (nOPV2), was bioengineered to have increased genetic stability compared to Sabin OPV and recommended for outbreak response Emergency Use Listing by WHO. Although pregnant women are not a target populat...

Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique

J. infect. dis; 226 (2), 2022
The global polio eradication initiative (gpei) has made steady progress toward the eradication target since its inception in 1988 [1]. the number of paralytic cases due to wild poliovirus has declined worldwide by >99.9%, and 2 of the 3 wild poliovirus serotypes have been declared eradicated by an indepe...

Assessing the “window of susceptibility” in measles control: The case study of Mozambique

Measles elimination has been on the World Health Organization agenda for the last fifteen years. Progress towards elimination has been made. However, it has not been uniform around the world. On the African continent, the vaccine coverage rate is the lowest in the world and the disease burden is the high...